Clinical Trial Update: A PoC Study to Evaluate Treatments' Efficacy by Monitoring MRD Using ctDNA in HR-positive/HER2-negative EBC Population [Phase 2]

View source ↗

Summary

This is a Phase 2 proof-of-concept clinical trial assessing treatments' efficacy in HR-positive/HER2-negative early breast cancer by monitoring minimal residual…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: MedSIR | Conditions: Breast Cancer | Phase 2 | Status: RECRUITING